Suppr超能文献

巴顿病中缺陷的CLN3蛋白的生物合成及细胞内靶向定位

Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.

作者信息

Järvelä I, Sainio M, Rantamäki T, Olkkonen V M, Carpén O, Peltonen L, Jalanko A

机构信息

National Public Health Institute, Department of Human Molecular Genetics, Mannerheimintie 166, 00300 Helsinki, Finland.

出版信息

Hum Mol Genet. 1998 Jan;7(1):85-90. doi: 10.1093/hmg/7.1.85.

Abstract

Batten disease (juvenile-onset neuronal ceroid lipofuscinosis, JNCL), the most common neurodegenerative disorder of childhood, is caused by mutations in a recently identified gene ( CLN3 ) localized to chromosome 16p11.2-12.1. To elucidate the biosynthesis and localization of the CLN3 protein, we expressed CLN3 cDNA in COS-1 and HeLa cell lines. In vitro translation, immunoprecipitation and Western blotting analyses detected an approximately 43 kDa polypeptide. Pulse-chase experiments indicated that the CLN3 protein is synthesized as an N -glycosylated single-chain polypeptide, which was not detected in growth medium. Confocal immunofluorescence microscopy revealed that the CLN3 protein is localized to the lysosomal compartment. These results provide evidence that Batten disease can be classified as a member of lysosomal diseases.

摘要

巴顿病(青少年型神经元蜡样脂褐质沉积症,JNCL)是儿童期最常见的神经退行性疾病,由最近鉴定出的位于16号染色体p11.2 - 12.1区域的基因(CLN3)突变引起。为了阐明CLN3蛋白的生物合成和定位,我们在COS - 1和HeLa细胞系中表达了CLN3 cDNA。体外翻译、免疫沉淀和蛋白质印迹分析检测到一条约43 kDa的多肽。脉冲追踪实验表明,CLN3蛋白以N - 糖基化单链多肽的形式合成,在生长培养基中未检测到。共聚焦免疫荧光显微镜显示,CLN3蛋白定位于溶酶体区室。这些结果提供了证据,表明巴顿病可归类为溶酶体疾病的一种。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验